UniSuper Management Pty Ltd

Position in JNJ — Johnson & Johnson

CIK 1989400 MELBOURNE, VICTORIA, C3

Position in JNJ

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$166,485,969

+$35,138,335 QoQ

Shares Held

655,534

+22.0% QoQ

Ownership

0.027%

of shares outstanding

% of Portfolio

0.87%

of 13F equity value

Holder Rank

#230

of 4,676 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

UniSuper Management Pty Ltd holds $763,193,679 across 9 Drug Manufacturers - General names. JNJ ranks #2 (21.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	193,999	$232,688,239
2	JNJ	Johnson & Johnson This page	655,534	$166,485,969
3	MRK	Merck & Co., Inc.	1,188,632	$152,739,212
4	ABBV	AbbVie Inc.	369,817	$93,060,749
5	GILD	Gilead Sciences, Inc.	351,688	$44,432,261
6	AMGN	Amgen Inc	116,483	$42,180,823
7	PFE	Pfizer Inc	624,923	$15,048,145
8	BMY	Bristol Myers Squibb Co	224,641	$12,943,814

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$166,485,969	655,534	+22.0%	Shares	Sole	2026-08-14
2026-03-31	$131,347,634	537,341	+31.6%	Shares	Sole	2026-05-11
2025-12-31	$84,482,784	408,228	-6.5%	Shares	Sole	2026-02-12
2025-09-30	$80,939,167	436,518	+15.4%	Shares	Sole	2025-10-31
2025-06-30	$57,771,577	378,210	-9.1%	Shares	Sole	2025-07-22
2025-03-31	$69,005,692	416,098	+1.8%	Shares	Sole	2025-05-15
2024-12-31	$59,116,606	408,772	-17.2%	Shares	Sole	2025-02-12
2024-09-30	$80,002,053	493,657	-0.7%	Shares	Sole	2024-11-14
2024-06-30	$72,681,714	497,275	-34.8%	Shares	Sole	2024-08-05
2024-03-31	$120,740,415	763,262	-10.8%	Shares	Sole	2024-05-13
2023-12-31	$134,166,305	855,980	-2.1%	Shares	Sole	2024-02-13
2023-09-30	$136,181,570	874,360	-19.5%	Shares	Sole	2023-11-13
2023-06-30	$179,774,085	1,086,117	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.